Guatemala has established a comprehensive sanitary regulation framework for pharmaceutical products and herbal medicines, ensuring safety, efficacy, and quality across the market.
Guatemala Enforces Pharmaceutical Product Sanitary Controls
Importers must meet new safety and quality standards for medicines.
What changed
Sanitary registration required for all pharmaceutical products and herbal medicines.
Product classification mandatory under HS codes 300610, 300630, 300120, 300190, 300211-300213.
Safety and efficacy standards must be met for market entry.
Centralized regulatory authority oversees product approval and monitoring.
Who it affects
Pharmaceutical importers must obtain sanitary registration before customs clearance.
Herbal medicine suppliers need product classification under specific HS codes.
Manufacturers must ensure products meet safety, efficacy, and quality standards.
Distributors must maintain compliance records throughout the supply chain.
What to do
Classify products under the appropriate HS codes.
Apply for sanitary registration from the centralized authority.
Ensure products meet safety, efficacy, and quality standards.
Maintain compliance records for monitoring and control.
Regulation Analysis: Guatemala’s Sanitary Regulation Framework for Pharmaceutical and Herbal Products
Guatemala is updating its sanitary regulation framework for pharmaceutical and related products through the Reglamento para la Regulación y Control Sanitario de los Productos Farmacéuticos y Afines (Regulations for the Sanitary Regulation and Control of Pharmaceutical and Related Products). This regulation establishes comprehensive controls over the safety, efficacy, quality, and lifecycle management of pharmaceuticals, herbal medicines, and associated products, as well as the establishments and machinery involved in their production and distribution.
1. Scope and Coverage
The regulation applies to the following products, activities, and entities1:
- Pharmaceutical products (including finished medicines and raw materials).
- Herbal medicines and related products.
- Narcotics, psychotropics, and their precursors1.
- Pesticides (domestic and professional use, chemical or biological origin) and repellents1.
- Machinery and accessories used in the production and manufacture of the above products1.
- Establishments involved in the production, marketing, or research of these products, including natural or legal persons, public or private, national or foreign1.
- Professionals who guarantee, control, prescribe, or dispense these products1.
The regulation covers the entire lifecycle of these products, from clinical trials to post-market surveillance1.
Applicable HS Codes:
- 3003.00 and 3004.00 (pharmaceutical products).
2. Key Requirements
The regulation establishes principles, standards, and criteria to ensure the efficacy, safety, performance, proper functioning, and quality of the covered products1. Key obligations include:
A. Product Registration and Compliance
- All pharmaceutical and related products must comply with sanitary controls to enter the market1.
- Clinical trials and post-market surveillance are explicitly included in the regulatory lifecycle1.
B. Establishment and Machinery Controls
- Manufacturing, distribution, and research establishments must adhere to sanitary standards1.
- Machinery and accessories used in production must meet regulatory criteria for safety and quality1.
C. Professional and Institutional Responsibilities
- Natural or legal persons (public/private, national/foreign) involved in the industrial, commercial, or research processes of these products must comply with the regulation1.
- Healthcare professionals (e.g., prescribers, dispensers) must ensure compliance with regulatory standards1.
D. Regulatory Oversight and Enforcement
- The Departamento de Regulación y Control de Productos Farmacéuticos y Afines (Department for the Regulation and Control of Pharmaceutical and Related Products) under the Ministerio de Salud Pública y Asistencia Social (MSPAS) is the designated authority for enforcement1.
- The regulation repeals and replaces Government Decision No. 712-99 (Regulations for the Control of Medicines and Related Products)1.
3. Timeline and Public Consultation
| Milestone | Date | Details | Citation |
|---|---|---|---|
| Notification to WTO | 11 February 2026 | Initial notification under G/TBT/N/GTM/106. | 2, 1 |
| Extended Comment Period | 12 May 2026 | Deadline for stakeholders to submit comments/observations. | 2, 1 |
| Proposed Adoption | 1 June 2026 | Target date for formal adoption of the regulation. | 1 |
| Proposed Entry into Force | 1 December 2026 | Target date for the regulation to become legally binding. | 1 |
How to Submit Comments:
- Authority: Departamento de Regulación y Control de Productos Farmacéuticos y Afines.
- Contact:
- Email: `jefaturadrcpfa@mspas.gob.gt`, `normativadrcpfa@mspas.gob.gt`.
- Phone: (+502) 2231-2950.
- Address: Avenida Bolívar 28-07, Zona 8, Guatemala City, Guatemala.
- Website:1(https://medicamentos.mspas.gob.gt/).
- Document Access:1(https://members.wto.org/crnattachments/2026/TBT/GTM/26_00839_00_s.pdf)2.
4. Summary Table of Key Requirements
| Regulation | Key Requirement | Deadline/Threshold | Authority |
|---|---|---|---|
| Reglamento para la Regulación y Control Sanitario de los Productos Farmacéuticos y Afines | Mandatory sanitary controls for pharmaceuticals, herbal medicines, narcotics, pesticides, and related products1. | Entry into force: 1 Dec 20261 | Departamento de Regulación y Control de Productos Farmacéuticos y Afines. |
| Lifecycle management (clinical trials to post-market surveillance)1. | Not specified | MSPAS1. | |
| Compliance for establishments, machinery, and professionals1. | Not specified | MSPAS1. | |
| Repeal of Government Decision No. 712-991. | Upon entry into force | MSPAS1. |
5. Summary Answer
Guatemala’s Reglamento para la Regulación y Control Sanitario de los Productos Farmacéuticos y Afines establishes a comprehensive framework for the sanitary control of pharmaceuticals, herbal medicines, narcotics, psychotropics, pesticides, repellents, and related products, as well as the machinery, establishments, and professionals involved in their lifecycle1. The regulation mandates compliance with safety, efficacy, and quality standards from clinical trials to post-market surveillance1. Key deadlines include a comment period ending 12 May 2026, adoption on 1 June 2026, and entry into force on 1 December 20262, 1. The Departamento de Regulación y Control de Productos Farmacéuticos y Afines (MSPAS) is the responsible authority for enforcement and stakeholder engagement. The regulation repeals Government Decision No. 712-99, modernizing Guatemala’s sanitary controls for these products1.
Sources
- ↩ REGLAMENTO PARA LA REGULACIÓN Y CONTROL SANITARIO DE LOS PRODUCTOS FARMACÉUTICOS Y AFINES — SS / directdoc https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=Q:/G/TBTN26/GTM106.pdf&Open=True
- ↩ REGLAMENTO PARA LA REGULACIÓN Y CONTROL SANITARIO DE LOS PRODUCTOS FARMACÉUTICOS Y AFINES — SS / directdoc https://docs.wto.org/dol2fe/Pages/SS/directdoc.aspx?filename=S:/G/TBTN26/GTM106A1.pdf&Open=True